BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MITF, WS2A, ENSG00000187098, 4286
105 results:

  • 1. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
    Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
    Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The GATOR2 complex maintains lysosomal-autophagic function by inhibiting the protein degradation of MiT/TFEs.
    Yang S; Ting CY; Lilly MA
    Mol Cell; 2024 Feb; 84(4):727-743.e8. PubMed ID: 38325378
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
    Linos K
    J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for mitf family aberrations.
    Wang XM; Shao L; Xiao H; Myers JL; Pantanowitz L; Skala SL; Udager AM; Vaishampayan U; Mannan R; Dhanasekaran SM; Chinnaiyan AM; Betz BL; Brown N; Mehra R
    Am J Clin Pathol; 2023 Dec; 160(6):549-554. PubMed ID: 37499055
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Vascular Expression of Prostate-specific Membrane Antigen (PSMA) in mitf Family Translocation Renal Cell Carcinoma and Related Neoplasms.
    Baraban EG; Ged Y; Singla N; Allaf ME; Gorin MA; Markowski MC; Rowe SP; Argani P
    Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):544-549. PubMed ID: 37471632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidental Detection of
    Repetto F; Sirohi D; Greipp P; Mahlow J
    Int J Surg Pathol; 2024 May; 32(3):551-555. PubMed ID: 37394760
    [No Abstract]    [Full Text] [Related]  

  • 7. Renal Cell Carcinoma of Variant Histology: Biology and Therapies.
    Msaouel P; Genovese G; Tannir NM
    Hematol Oncol Clin North Am; 2023 Oct; 37(5):977-992. PubMed ID: 37244822
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
    Vokshi BH; Davidson G; Tawanaie Pour Sedehi N; Helleux A; Rippinger M; Haller AR; Gantzer J; Thouvenin J; Baltzinger P; Bouarich R; Manriquez V; Zaidi S; Rao P; Msaouel P; Su X; Lang H; Tricard T; Lindner V; Surdez D; Kurtz JE; Bourdeaut F; Tannir NM; Davidson I; Malouf GG
    Nat Commun; 2023 May; 14(1):3034. PubMed ID: 37236926
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
    Lang M; Schmidt LS; Wilson KM; Ricketts CJ; Sourbier C; Vocke CD; Wei D; Crooks DR; Yang Y; Gibbs BK; Zhang X; Klumpp-Thomas C; Chen L; Guha R; Ferrer M; McKnight C; Itkin Z; Wangsa D; Wangsa D; James A; Difilippantonio S; Karim B; Morís F; Ried T; Merino MJ; Srinivasan R; Thomas CJ; Linehan WM
    J Exp Clin Cancer Res; 2023 Apr; 42(1):99. PubMed ID: 37095531
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Natural History of Pancreatic Cystic Lesions in Liver Transplant Recipients: A Systematic Review and Meta-analysis.
    Canakis A; Vittal A; Deliwala S; Twery B; Canakis J; Patel P; Chahal P
    Pancreas; 2022 Oct; 51(9):1160-1166. PubMed ID: 37078940
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma.
    Bersanelli M; Rebuzzi SE; Roviello G; Catalano M; Brunelli M; Rizzo M
    Hum Vaccin Immunother; 2023 Dec; 19(1):2171672. PubMed ID: 36758960
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.
    Kuentz MA; Blons H; Gimenez-Roqueplo AP; Just PA; Laurent-Puig P; Mejean A; Oudard S; Verkarre V
    Genes Chromosomes Cancer; 2023 Jun; 62(6):361-366. PubMed ID: 36695651
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MiT/TFE Family Renal Cell Carcinoma.
    Tang J; Baba M
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672892
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma.
    Sangoi AR; Al-Obaidy KI; Cheng L; Kao CS; Chan E; Sadasivan S; Levin AM; Alvarado-Cabrero I; Kunju LP; Mehra R; Mannan R; Wang X; Dhillon J; Tretiakova M; Smith SC; Hes O; Williamson SR
    Histopathology; 2023 Apr; 82(5):684-690. PubMed ID: 36564980
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. mitf/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights.
    Simonaggio A; Ambrosetti D; Verkarre V; Auvray M; Oudard S; Vano YA
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886994
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression.
    Kammerer-Jacquet SF; Gandon C; Dugay F; Laguerre B; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Leroy X; Aubert S; Vermaut C; Escande F; Verkarre V; Compérat E; Ambrosetti D; Pedeutour F; Belaud-Rotureau MA; Rioux-Leclercq N;
    Histopathology; 2022 Aug; 81(2):228-238. PubMed ID: 35562857
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Renal cell carcinoma in children and adolescents: a retrospective study of a French-Italian series of 93 cases.
    Denize T; Massa S; Valent A; Militti L; Bertolotti A; Barisella M; Rioux-Leclercq N; Malouf GG; Spreafico F; Verschuur A; van der Beek J; Tytgat L; van den Heuvel-Eibrink MM; Vujanic G; Collini P; Coulomb A
    Histopathology; 2022 May; 80(6):928-945. PubMed ID: 35238063
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A review of neoplasms with mitf/MiT family translocations.
    Wei S; Testa JR; Argani P
    Histol Histopathol; 2022 Apr; 37(4):311-321. PubMed ID: 35107169
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Integrative clinical and molecular characterization of translocation renal cell carcinoma.
    Bakouny Z; Sadagopan A; Ravi P; Metaferia NY; Li J; AbuHammad S; Tang S; Denize T; Garner ER; Gao X; Braun DA; Hirsch L; Steinharter JA; Bouchard G; Walton E; West D; Labaki C; Dudani S; Gan CL; Sethunath V; Carvalho FLF; Imamovic A; Ricker C; Vokes NI; Nyman J; Berchuck JE; Park J; Hirsch MS; Haq R; Mary Lee GS; McGregor BA; Chang SL; Feldman AS; Wu CJ; McDermott DF; Heng DYC; Signoretti S; Van Allen EM; Choueiri TK; Viswanathan SR
    Cell Rep; 2022 Jan; 38(1):110190. PubMed ID: 34986355
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.